Actavis to spend $66B on Allergan

  • By Tom Murphy Associated Press
  • Monday, November 17, 2014 1:23pm
  • Business

Actavis will pay $66 billion to buy fellow drugmaker Allergan in a deal that could finally end a months-long takeover push from Valeant Pharmaceuticals for the Botox maker.

Actavis said Monday that it will spend $219 in cash and stock for each share of Allergan.

Valeant said separately that the Actavis bid was a price it “cannot justify to its own shareholders.”

The Canadian drugmaker went public with its offer for Allergan in April and had raised its bid at the end of May to $53 billion. That was valued at the time at about $179 in cash and stock.

Valeant’s stock has climbed since it made that offer, so the deal would worth $183.39 per share based on Friday’s closing price for Valeant.

Valeant Pharmaceuticals International Inc. partnered with the hedge fund and Allergan shareholder Pershing Square Capital Management on the bid.

Allergan Inc. resisted that deal for months, but its board has unanimously approved the Actavis offer, and Allergan management supports it as well.

“We are combining with a partner that is ideally suited to realize the full potential inherent in our franchise,” Allergan Chairman and CEO David E.I. Pyott said in a statement from the companies.

Allergan had questioned Valeant’s business model, which relies on acquisitions for growth, and its cost-cutting plans. Valeant has said it is committed to funding important research.

The companies have taken their takeover battle to federal court, and Allergan faces a Dec. 18 shareholder meeting at which its stock owners will have a chance to vote out most of its board. A federal judge decided earlier this month that Pershing Square can vote in that meeting, but Allergan has said it would appeal that decision.

In shunning Valeant, Allergan is favoring another drugmaker that leans heavily on acquisitions. In July, Actavis completed a $28 billion deal for fellow drugmaker Forest Laboratories. Last year, it bought Ireland’s Warner Chilcott for $8.5 billion and moved its headquarters to Dublin from Parsippany, New Jersey. That came a year it merged with generic drugmaker Watson Pharmaceuticals.

Actavis PLC also announced another deal update on Monday. It said it completed its offer to buy all outstanding shares of Durata Therapeutics Inc. in a deal worth about $675 million.

Shares of Irvine, California-based Allergan jumped more than 7 percent, or $14.57, to $213.22 Monday morning after the deal was announced. The shares had started climbing hours before after several reports of a possible acquisition first surfaced. U.S.-traded shares of Actavis rose 3.9 percent, or $9.47, to $253.24; and Valeant climbed about $2 to 136.24.

Broader indexes were nearly flat.

Talk to us

> Give us your news tips.

> Send us a letter to the editor.

> More Herald contact information.

More in Business

The livery on a Boeing plane. (Christopher Pike / Bloomberg)
Former Lockheed Martin CFO joins Boeing as top financial officer

Boeing’s Chief Financial Officer is being replaced by a former CFO at… Continue reading

Izaac Escalante-Alvarez unpacks a new milling machine at the new Boeing machinists union’s apprentice training center on Friday, June 6, 2025 in Everett, Washington. (Olivia Vanni / The Herald)
Boeing Machinists union training center opens in Everett

The new center aims to give workers an inside track at Boeing jobs.

Some SnoCo stores see shortages after cyberattack on grocery supplier

Some stores, such as Whole Foods and US Foods CHEF’STORE, informed customers that some items may be temporarily unavailable.

People take photos and videos as the first Frontier Arlines flight arrives at Paine Field Airport under a water cannon salute on Monday, June 2, 2025 in Everett, Washington. (Olivia Vanni / The Herald)
Water cannons salute Frontier on its first day at Paine Field

Frontier Airlines joins Alaska Airlines in offering service Snohomish County passengers.

Amit B. Singh, president of Edmonds Community College. 201008
Edmonds College and schools continue diversity programs

Educational diversity programs are alive and well in Snohomish County.

A standard jet fuel, left, burns with extensive smoke output while a 50 percent SAF drop-in jet fuel, right, puts off less smoke during a demonstration of the difference in fuel emissions on Tuesday, March 28, 2023 in Everett, Washington. (Olivia Vanni / The Herald)
Sustainable aviation fuel center gets funding boost

A planned research and development center focused on sustainable aviation… Continue reading

Helion's 6th fusion prototype, Trenta, on display on Tuesday, July 9, 2024 in Everett, Washington. (Olivia Vanni / The Herald)
Helion celebrates smoother path to fusion energy site approval

Helion CEO applauds legislation signed by Gov. Bob Ferguson expected to streamline site selection process.

Pharmacist John Sontra and other employees work on calling customers to get their prescriptions transferred to other stores from the Bartell Drugs Pharmacy on Hoyt Avenue on Wednesday, July 2, 2025 in Everett, Washington. (Olivia Vanni / The Herald)
Bartell Drugs location shutters doors in Everett

John Sontra, a pharmacist at the Hoyt Avenue address for 46 years, said Monday’s closure was emotional.

Wine is illuminated on a large win rack at the center of the main room at Long Shadows Woodinville Tasting Room & Key Club Lounge on Friday, Feb. 28, 2025 in Woodinville, Washington. (Olivia Vanni / The Herald)
Two winery restaurants in Woodinville stand out

You wouldn’t expect to get world-class pizza at a winery,… Continue reading

Support local journalism

If you value local news, make a gift now to support the trusted journalism you get in The Daily Herald. Donations processed in this system are not tax deductible.